Key Takeaways
- A former Trump-era FDA commissioner suggested that industry try to avoid conducting user fee negotiations during the beginning of the new Trump administration.
Scott Gottlieb, who served as US Food and Drug Administration commissioner during the first half of president Trump’s first term,...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?